Medinotec MDNC Ratios (2022-2026)

OTC MDNC
$5.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Medinotec Quarterly Ratios

Periods 18 quarters
Latest May 2026

Medinotec reported a gross margin of 49.33% and a net margin of 7.86% for the quarter ended May 2026. These financial ratios cover 18 quarters of results from Feb 2022 through May 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Profitability
Gross Margin 77.15%56.22%63.62%57.55%57.88%76.33%82.61%43.14%43.14%47.95%46.20%40.58%66.49%42.79%61.87%53.06%46.90%49.33%
EBT Margin -32.04%-42.71%-161.39%-4.33%-25.60%4.88%-9.05%-21.44%8.31%17.11%22.45%18.77%54.56%12.31%16.59%21.39%-14.99%7.86%
EBIT Margin -32.31%-24.43%-127.02%6.57%-15.58%9.81%15.89%12.88%10.93%21.50%24.15%20.56%55.58%13.00%16.33%21.79%-14.50%6.82%
EBITDA Margin -32.31%-24.43%-127.02%6.57%-15.58%9.81%15.89%12.88%10.93%21.50%24.15%20.56%55.58%13.00%16.33%21.79%-14.50%6.82%
Operating Margin -32.31%-24.43%-127.02%6.57%-15.58%9.81%15.89%12.88%10.93%21.50%24.15%20.56%55.58%13.00%16.33%21.79%-14.50%6.82%
Net Margin -21.02%-42.71%-161.39%5.66%-25.60%4.41%-12.55%-24.59%17.79%6.97%16.32%12.96%90.96%24.63%10.59%20.86%-25.61%7.86%
FCF Margin -7.87%-24.49%-384.45%-86.26%128.69%-66.00%-1.86%19.10%-0.15%21.18%22.05%2.56%9.26%-35.58%37.81%22.20%-4.11%-8.17%
Efficiency
Inventory AverageInventory Avg. 0.51M0.42M0.56M0.67M0.79M0.91M1.12M1.21M1.07M0.96M0.96M1.10M1.22M1.33M
Assets AverageAssets Avg. 4.79M4.59M4.81M4.46M4.40M4.56M4.81M5.33M6.09M7.11M6.89M6.61M6.83M6.90M
Asset Utilization RatioAsset Util. 0.210.270.300.681.141.281.521.481.501.411.661.731.421.49
Leverage & Solvency
Interest Coverage RatioInterest Cover -14.431.133.230.390.11-0.62-0.79-3.87-3.324.649.2512.1570.208.6913.1277.67-31.9126.34
Times Interest Earned -14.431.133.230.390.11-0.62-0.79-3.87-3.324.649.2512.1570.208.6913.1277.67-31.9126.34
Valuation
Price to EarningsP/E -0.00M-119.16146.53672.78199.32176.4518.30111.83171.42111.07-125.96281.91
Price to SalesP/S 167.2529.3026.0746.8632.5222.8716.6427.5418.1623.1732.2622.17
Price to BookP/B 22.8528.2727.0726.0723.1920.7613.7413.4512.1510.6910.2910.04
Enterprise Value 55.08M54.65M54.62M55.00M55.04M55.43M56.82M57.86M57.91M57.70M57.73M58.19M
EV to EBIT 988.20211.90221.95204.32126.31105.1029.00208.53109.56104.40-218.50321.74
EV to EBITDA 988.20211.90221.95204.32126.31105.1029.00208.53109.56104.40-218.50321.74
Market Capitalization 58.67M58.67M58.67M58.67M58.67M58.67M58.67M58.78M58.78M58.78M58.78M58.78M
Price to FCFP/FCF -0.01M153.39-0.02M221.24147.47894.78179.63-77.4248.04104.38-784.77-271.52
EV to FCF -0.01M142.88-0.02M207.38138.35845.43173.96-76.2147.33102.47-770.83-268.83
EV to CFO -0.01M142.88-0.01M212.23130.54401.13174.68-76.2147.33102.47-770.83-330.41
Return Ratios
Return on Sales [ROS]ROS -32.31%-24.43%-127.02%6.57%-15.58%9.81%15.89%12.88%10.93%21.50%24.15%20.56%55.58%13.00%16.33%21.79%-14.50%6.82%
Return on Capital Employed [ROCE]ROCE -5.05%-3.32%1.68%7.54%16.82%21.86%37.28%38.36%69.67%63.80%61.50%63.08%19.10%17.30%
Return on Assets [ROA]ROA -7.36%-5.45%-1.56%-13.22%-2.68%-1.07%6.02%20.91%64.42%61.34%63.99%69.63%13.63%8.90%